Breaking News, Collaborations & Alliances

Amatsi, Avogadro To Join Forces in Discovery

Amatsi (formerly known as CRID Pharma) and Avogadro will join forces in an effort to provide a broader range of drug development services to their respective pharma and biopharma clients.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Amatsi (formerly known as CRID Pharma) and Avogadro will join forces in an effort to provide a broader range of drug development services to their respective pharma and biopharma clients. Together, the companies will have more than 175 staff located in France and the U.S. By combining their expertise and know-how, the group aims to provide its clients with an increased range of services including: Galenic development, analytical development, bioanalysis, PK-ADME studies, residues, etc., qual...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters